ロード中...
The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
INTRODUCTION: The classification of patients with prostate cancer is used to determine treatments based on risk factors. The presence of secondary circulating prostate tumour cells (CPCs) detected in peripheral blood after a curative treatment has been associated with a worse prognosis. We present a...
保存先:
| 出版年: | Ecancermedicalscience |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cancer Intelligence
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027969/ https://ncbi.nlm.nih.gov/pubmed/30034521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.844 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|